LOW-VOLUME · HOSP-HEAVY

cabergoline Side Effects

cabergoline (also sold as Dostinex) is a LOW-VOLUME FAERS extract #398 of 524 by FAERS report count. Still opens on HOSP-HEAVY: 33.2% mention hospitalization (1,549 reports).

Data updated 2026-05-15

4,670
FAERS reports

Thinner FAERS book - still a temporal association ledger, not proof of cause. Methodology.

cabergoline: 33.2% mention hospitalization (1,549 reports). Death stamp DEATH-HEAVY; volume band LOW-VOLUME #398 of 524 by FAERS report count.

Thinner FAERS extract for cabergoline (Dostinex) (4,670 reports #398 of 524 by FAERS report count). 33.2% mention hospitalization (1,549 reports). Sparse books still carry named reaction rows when present; not medical advice.

Counts from the openFDA FAERS extract (2004–2025). Stamps SIGNAL · DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED.

HEADACHE leads 319 of 4,670 reports

HEADACHE
319
FATIGUE
275
NAUSEA
274
DIZZINESS
224
MALAISE
209
PAIN
195
DIARRHOEA
175
CONDITION AGGRAVATED
170
ANXIETY
158
RASH
155
VOMITING
154
FALL
150
ABDOMINAL DISCOMFORT
148
DRUG INTERACTION
142
WEIGHT DECREASED
138
ASTHENIA
133
ARTHRALGIA
128

Who reports · age peak 18-44 (SEX-BALANCED)

Sex coding · SEX-BALANCED

Female 2,447 (59%)
Male 1,693 (41%)
Unknown 32

Age peak 18-44 (1,209 reports)

0-17 79 (2%)
18-44 1,209 (37%)
45-64 1,090 (34%)
65-74 559 (17%)
75+ 303 (9%)

FAERS filings rising toward 2025

2004 2025

Reactions in Death Reports

Death-mentioned subset is HEAVY here (245 reports, 5.2%). Top co-reported reactions in that subset - voluntary, not causal.

Reaction Reports
LUNG NEOPLASM MALIGNANT 46
CONDITION AGGRAVATED 45
ARTHROPATHY 42
ABDOMINAL DISCOMFORT 41
DEATH 41
INFLAMMATION 41
LOWER RESPIRATORY TRACT INFECTION 41
RASH 41
COVID-19 40
PULMONARY PAIN 40
OVERDOSE 39
RADIATION INFLAMMATION 39
DRUG ABUSE 38
INTENTIONAL PRODUCT MISUSE 37
SCHIZOPHRENIA 36
KNEE ARTHROPLASTY 29
MALAISE 27
DIARRHOEA 26

Reactions in Hospitalization Reports

Hospitalization is HEAVY (1,549, 33.2% of the book). Top reactions in those rows:

Reaction Reports
DRUG ABUSE 111
RASH 110
ARTHROPATHY 103
FALL 102
LOWER RESPIRATORY TRACT INFECTION 98
PULMONARY PAIN 96
ABDOMINAL DISCOMFORT 95
INTENTIONAL PRODUCT MISUSE 95
OVERDOSE 92
HEADACHE 90
CONDITION AGGRAVATED 88
FATIGUE 86
MALAISE 85
DIZZINESS 83
VOMITING 77
KNEE ARTHROPLASTY 73
ANXIETY 68
How to read cabergoline FAERS figures (SIGNAL · DEATH-HEAVY · HOSP-HEAVY)

FAERS holds 4,670 voluntary reports linked to cabergoline (Dostinex), 2004-2025. Death is listed on 245 (5.2%). Hospitalization appears on 1,549 (33.2%). Top co-reported indication: Product Used For Unknown Indication.

Sparse extract - named reactions and SEX-BALANCED skew still differ by drug; not a complete safety profile.

Read with cabergoline

Peers ranked by ABS(total_reports), then an ABS(death_share) pole; guide hop follows DEATH-HEAVY · HOSP-HEAVY stamps.